Fumiaki Ando

1.2k total citations
58 papers, 799 citations indexed

About

Fumiaki Ando is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Fumiaki Ando has authored 58 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Nephrology. Recurrent topics in Fumiaki Ando's work include Ion Transport and Channel Regulation (19 papers), Electrolyte and hormonal disorders (10 papers) and Renal and related cancers (8 papers). Fumiaki Ando is often cited by papers focused on Ion Transport and Channel Regulation (19 papers), Electrolyte and hormonal disorders (10 papers) and Renal and related cancers (8 papers). Fumiaki Ando collaborates with scholars based in Japan, United States and Nepal. Fumiaki Ando's co-authors include Shinichi Uchida, Eisei Sohara, Tatemitsu Rai, Takayasu Mori, Naohiro Nomura, Koichiro Susa, Shintaro Mandai, Yutaro Mori, Kiyoshi Isobe and Sei Sasaki and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and PLoS ONE.

In The Last Decade

Fumiaki Ando

50 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumiaki Ando Japan 18 449 186 130 104 102 58 799
Leping Shao China 15 375 0.8× 114 0.6× 85 0.7× 80 0.8× 117 1.1× 54 572
Denis J. Glenn United States 14 241 0.5× 72 0.4× 38 0.3× 180 1.7× 65 0.6× 15 908
Xiaoyan Song China 14 122 0.3× 63 0.3× 87 0.7× 10 0.1× 88 0.9× 25 622
Laura Calleros Spain 15 283 0.6× 54 0.3× 115 0.9× 19 0.2× 23 0.2× 31 581
Bryn S. Moore United States 11 557 1.2× 80 0.4× 57 0.4× 36 0.3× 71 0.7× 15 994
Betty S. van der Veen Netherlands 7 172 0.4× 151 0.8× 33 0.3× 35 0.3× 28 0.3× 13 693
Shenglan Yang China 15 612 1.4× 40 0.2× 35 0.3× 19 0.2× 15 0.1× 37 1.1k
J Vávrová Czechia 17 225 0.5× 75 0.4× 83 0.6× 110 1.1× 20 0.2× 60 793
Rong Gu China 21 409 0.9× 59 0.3× 40 0.3× 10 0.1× 153 1.5× 62 1.1k
Sue Lynn Lau Australia 10 257 0.6× 46 0.2× 12 0.1× 104 1.0× 26 0.3× 15 1.0k

Countries citing papers authored by Fumiaki Ando

Since Specialization
Citations

This map shows the geographic impact of Fumiaki Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Ando more than expected).

Fields of papers citing papers by Fumiaki Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiaki Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Ando. The network helps show where Fumiaki Ando may publish in the future.

Co-authorship network of co-authors of Fumiaki Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiaki Ando. A scholar is included among the top collaborators of Fumiaki Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiaki Ando. Fumiaki Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandai, Shintaro, Yuta Nakano, Yutaro Mori, et al.. (2025). Perioperative antihypertensive medications and effects on functional decline and mortality in non-cardiac surgery. European Heart Journal Open. 5(4). oeaf096–oeaf096.
2.
Fujimaru, Takuya, Takayasu Mori, Motoko Chiga, et al.. (2024). Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology. Kidney International Reports. 9(4). 994–1004. 5 indexed citations
3.
Mandai, Shintaro, Fumiaki Ando, Takayasu Mori, et al.. (2024). Associations Between Dietary Potassium Intake From Different Food Sources and Hyperkalemia in Patients With Chronic Kidney Disease. Journal of Renal Nutrition. 34(6). 519–529. 3 indexed citations
4.
Nakano, Yuta, Shintaro Mandai, Daiei Takahashi, et al.. (2024). Sex disparities in the risk of urgent dialysis following acute aortic dissections in Japan. iScience. 27(8). 110577–110577.
5.
Fujimaru, Takuya, Takayasu Mori, Akinari Sekine, et al.. (2024). Importance of IFT140 in Patients with Polycystic Kidney Disease Without a Family History. Kidney International Reports. 9(9). 2685–2694.
6.
7.
Mandai, Shintaro, Motoko Chiga, Kouhei Yamamoto, et al.. (2023). Circulating Extracellular Vesicle-Propagated microRNA Signature as a Vascular Calcification Factor in Chronic Kidney Disease. Circulation Research. 132(4). 415–431. 38 indexed citations
8.
Nakano, Yuta, Shintaro Mandai, Shotaro Naito, et al.. (2023). Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults. Bone. 179. 116975–116975. 18 indexed citations
9.
Ando, Fumiaki, Shintaro Mandai, Koichiro Susa, et al.. (2023). ZNF185 prevents stress fiber formation through the inhibition of RhoA in endothelial cells. Communications Biology. 6(1). 29–29. 6 indexed citations
10.
Mandai, Shintaro, Yutaro Mori, Fumiaki Ando, et al.. (2023). National Trends in Mortality and Urgent Dialysis after Acute Hypertension in Japan From 2010 Through 2019. Hypertension. 80(12). 2591–2600. 2 indexed citations
11.
Mori, Takayasu, Shintaro Mandai, Yutaro Mori, et al.. (2023). Thrombocytopenia during avacopan administration: A case report. International Journal of Rheumatic Diseases. 26(8). 1603–1607. 3 indexed citations
12.
Mandai, Shintaro, Hiroki Shiwaku, Yutaro Mori, et al.. (2023). Chronic kidney disease causes blood-brain barrier breakdown via urea-activated matrix metalloproteinase-2 and insolubility of tau protein. Aging. 15(20). 10972–10995. 19 indexed citations
13.
Nakano, Yuta, Shintaro Mandai, Fumiaki Ando, et al.. (2022). Nationwide mortality associated with perioperative acute dialysis requirement in major surgeries. International Journal of Surgery. 104. 106816–106816. 3 indexed citations
14.
Mandai, Shintaro, Fumiaki Ando, Takayasu Mori, et al.. (2021). Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study. PLoS ONE. 16(11). e0258846–e0258846. 4 indexed citations
15.
Kikuchi, Hiroaki, Takuya Fujimaru, Kenichi Asano, et al.. (2021). Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney. Clinical and Experimental Nephrology. 25(5). 445–455. 7 indexed citations
16.
Sohara, Eisei, Shintaro Mandai, Hiroaki Kikuchi, et al.. (2020). Renal TNFα activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease. Kidney International. 97(4). 713–727. 34 indexed citations
17.
Arai, Yohei, Kenichi Asano, Shintaro Mandai, et al.. (2020). WNK1–TAK1 signaling suppresses lipopolysaccharide-induced cytokine production and classical activation in macrophages. Biochemical and Biophysical Research Communications. 533(4). 1290–1297. 10 indexed citations
18.
Mori, Takayasu, Motoko Chiga, Takuya Fujimaru, et al.. (2020). Phenotypic differences of mutation‐negative cases in Gitelman syndrome clinically diagnosed in adulthood. Human Mutation. 42(3). 300–309. 4 indexed citations
19.
Kikuchi, Hiroaki, Emi Sasaki, Naohiro Nomura, et al.. (2018). Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease. Kidney International. 95(1). 123–137. 29 indexed citations
20.
Mandai, Shintaro, Susumu Furukawa, Yutaka Hata, et al.. (2017). Loop diuretics affect skeletal myoblast differentiation and exercise-induced muscle hypertrophy. Scientific Reports. 7(1). 46369–46369. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leping Shao Breakdown of academic impact, for papers by Denis J. Glenn Breakdown of academic impact, for papers by Xiaoyan Song Breakdown of academic impact, for papers by Laura Calleros Breakdown of academic impact, for papers by Bryn S. Moore Breakdown of academic impact, for papers by Betty S. van der Veen Breakdown of academic impact, for papers by Shenglan Yang Breakdown of academic impact, for papers by J Vávrová Breakdown of academic impact, for papers by Rong Gu Breakdown of academic impact, for papers by Sue Lynn Lau
Rankless by CCL
2026